Excluding Breast Cancer
1 clinical trials · Condition
◉ Watch Excluding Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors (NCT01421004) | Novartis Pharmaceuticals | 2011-12-01 |
Track Excluding Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.